# Ensysce Biosciences, Inc.

Type: Company (ENSC)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/ensysce-biosciences-inc
Canonical HTML page: https://gethealthbrief.com/entity/ensysce-biosciences-inc

## Recent coverage (1 stories)

### ENSC Shorts Up 619.9% at $0.30; FCUV Revenue $0.05M
2026-08-13 01:23:24 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Ensysce Biosciences short interest soared 619.9% to 364,278 shares as its stock trades at $0.30, while Focus Universal posted just $0.05M in quarterly revenue. The data highlights severe financial fragility across two small healthcare and device innovators.
Full story: https://gethealthbrief.com/story/ensc-shorts-up-619-9-fcuv-revenue-0-05m

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.